Cutting edge: Sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease

Journal of Immunology

Volumn 162, Issue 8, 1999, Pages 4373-4376

  Buhlmann, Janet E ^a   Gonzalez, Mercedes ^a   Ginther, Brigit ^a   Panoskaltsis Mortari, Angela ^b   Blazar, Bruce R ^b   Greiner, Dale L ^c   Rossini, Aldo A ^c   Flavell, Richard ^d   Noelle, Randolph J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD40; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CELL INTERACTION; CELL TRANSFER; CYTOKINE PRODUCTION; GRAFT VERSUS HOST REACTION; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0033561547     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Gleichmann, E. S., S. T. Pals, A. G. Rolink, T. Radaszkiewicz, and H. Gleichmann. 1984. Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunol. Today 5:324.
2. Via, C. A., and G. M. Shearer. 1988. T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol. Today 9:207.
3. Rolink, A. G., S. T. Pals, and E. Gleichmann. 1983. Allosupressor and allohelper T cells in acute and chronic graft-versus host (GVH) disease. II F1 recipients carrying mutation of H-2K and/or 1-A. J. Exp. Med. 157:755.
4. Rolink, A. G., and E. Gleichmann. 1983. Allosupressor and allohelper T cells in acute and chronic graft-versus host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes. J. Exp. Med. 158:546.
5. + T cells. J. Immunol. 155:2396.
6. Durie, F. H., A. Aruffo, J. A. Ledbetter, K. M. Crassi, W. R. Green, and R. J. Noelle. 1994. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-versus-host disease. J. Clin. Invest. 94: 1333.
7. + T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J Immunol 158:29.
8. Xu, J., T. M. Foy, J. D. Laman, J. J. Dunn, T. J. Waldschmidt, J. Elsemore, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity 1:423.
9. Noelle, R. J., M. Roy, D. M. Shepherd, I. Stamenkovic, J. A. Ledbetter, and A. Aruffo. 1992. A novel ligand on activated T helper cells binds CD40 and transduces the signal for the cognate activation of B cells. Proc. Natl. Acad. Sci. USA 89:6550.
10. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russell, and D. Y. Loh. 1988. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 335:271.
11. Zhang, L. 1996. The fate of adoptively transferred antigen-specific T cells in vivo. Eur. J. Immunol. 26:2208.
12. Bennett, S. R. M., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478.
13. Schoenberger, S. P., R. E. M. Toes, E. I. H. van der Voort, R. Offringa, and C. J. M. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
14. + T-helper and a T-killer cell. Nature 393: 474.
15. Mackey, M. F., J. R. C. Gunn, C. Maliszewski, H. Kikutani, R. J. Noelle, and R. Barth. 1998. Dendritic cells require maturation via CD40 to generate protective antitumor immunity. J. Immunol. 161:2094.
16. Blazar, B. R., P. A. Taylor, P. S. Linsley, and D. S. Vallera. 1994. In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice. Blood 83:3815.
17. Blazar, B. R., P. A. Taylor, G. S. Gray, and D. A. Vallera. 1994 The role of T cell subsets in regulating the in vivo efficacy of CTLA4-Ig in preventing graft-versus-host disease in recipients of fully MHC or multiple minor histocompatibility-disparate donor inocula. Transplantation 58:1422.
18. Hakim, F. T., R. Cepeda, G. S. Gray, C. H. June, and R. Abe. 1995. Acute graft-versus-host reaction can be aborted by blockade of costimulatory molecules. J. Immunol. 155:1757.
19. Williamson, E., P. Garside, J. A. Bradley, and A. Mowat. 1996. IL-12 is a central mediator of acute graft versus host disease. J. Immunol. 157:689.